Low Clinical Burden of 2009 Pandemic Influenza A (H1N1) Infection during Pregnancy on the Island of La Réunion by Gérardin, Patrick et al.
Low Clinical Burden of 2009 Pandemic Influenza A
(H1N1) Infection during Pregnancy on the Island of La
Re ´union
Patrick Ge ´rardin
1,2,3*, Rachid El Amrani
4,B e ´atrice Cyrille















1Neonatal and Pediatric Intensive Care Unit, Centre Hospitalier Re ´gional (CHR), Saint Pierre, La Re ´union, France, 2Centre for Clinical Investigation–Clinical Epidemiology
(CIC–EC) of La Re ´union (INSERM/CHR/URMLR), Saint Pierre, La Re ´union, France, 3UMR S953, ‘‘Epidemiological Research on Perinatal Health and Women’s and Children’s
Health’’ (INSERM/Assistance Publique des Ho ˆpitaux de Paris), Paris, France, 4Obstetric and Gynecology Unit, CHR, Saint Pierre, La Re ´union, France, 5Fetopathology Unit,
CHR, Saint Pierre, La Re ´union, France, 6Intensive Care Unit, CHR, Saint Pierre, La Re ´union, France, 7Department of Medical Information, CHR, Saint Pierre, La Re ´union,
France, 8Department of Medical Information, CHR, Saint Denis, La Re ´union, France, 9Microbiology, CHR, Saint Denis, La Re ´union, France, 10Microbiology, CHR, Saint
Pierre, La Re ´union, France
Abstract
Background: Pregnant women have been identified as a group at risk, both for respiratory complications than for the
admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic (pdm). The purpose of this
prospective register-based cohort-study was to characterize the clinical virulence of the pdm (H1N1/09)v during pregnancy
in La Re ´union.
Methods/Principal Findings: Over a twelve-week pdm wave (13 July to 3 October 2009), 294 pregnant women presented
with an influenza-like illness (ILI) to one of the three maternity departments of the South Reunion area, Indian Ocean. Out of
these, 278 were checked by RT-PCR for influenza viruses (157 positive and 121 negative, of whom, 141 with pdm flu and 132
with ILIs of non pdm origin, 5 untyped). The median body temperature was higher in women experiencing pdm flu than in
those with non pdm ILI (38.9uC versus 38.3uC, P,0.0001), without evidence linked to circulating viremia. Oseltamivir was
given for 86% of pdm flu cases in a median time inferior than 48 hrs (range 0–7 days). The hospitalization rate for pdm flu
was of 60% and not associated with underlying conditions. Six viral pneumonia and fourteen asthma attacks were observed
among 84 hospitalized pdm flu cases, of whom, only one led to the ICU for an acute lung injury. No maternal death
occurred during the pdm wave. None adverse pregnancy outcome was associated with pdm flu. No congenital birth defect,
nor early-onset neonatal influenza infection was attributable to pdm flu exposure.
Conclusions/Significance: This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza
infection during pregnancy. The reasons for which the clinical burden of H1N1/09 influenza virus may differ worldwide raise
questions about a differential local viral-strain effect and public health preparedness, notably in timely access to special care
and antiviral treatments.
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Introduction
Since the beginning of the first third-millennium pandemic,
foremost was the concern that 2009 triple-reassortant pandemic
(pdm) H1N1 influenza (H1N1/09) virus could be more life-
threatening than its seasonal peers [1], as evidenced by its unusual
clinical burden in young adults [2–6], who experienced more than
half of Intensive Care Unit (ICU) stays and deaths [6–9], mainly
due to the acute respiratory distress syndrome (ARDS) compli-
cating pneumonia of viral origin [4,7–9].
In this context suggesting enhanced virulence for this novel
influenza strain, further supported by alveolar damage in animal
models reminiscent of highly pathogenic H5N1 avian viruses
[10–12], pregnant women, who exhibited higher case-fatality-
ratios (CFR) in past influenza pandemics [13,14], but also
increased admission rates to hospital in seasonal flu [15], have
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10896been stressed as a high-risk population for pdm influenza [16].
Indeed, out of thirteen states of the USA, between 15 April and 16
June, admission rates to hospital for pregnant women were four-
fold those of the US community. By the same period, among the
45 deaths notified to the US Centers of Disease Control and
Prevention (CDC), six were observed during gestation, highlight-
ing pregnant woman eligibility to a fatal issue [17]. Additionally, in
the USA, pregnant women for whom oseltamivir was delayed
beyond 48 hrs carried a four-fold risk to be admitted in the ICU
and a 30-fold risk to die [18], whilst the high cause-specific
maternal CFR anticipated that 2009 H1N1 influenza could
increase the 2009 maternal mortality ratio in the country [19].
Noteworthy, similar figures were found in the south hemisphere,
where pdm flu was shown increasing asthma, diabetes mellitus and
preterm labor during pregnancy in Australia, whereas very
preterm births, stillbirths and infant deaths heralded also adverse
perinatal outcomes [20,21]. However, Lim et al., in an Asian
perspective contrasted the pregnant woman vulnerability to pdm
flu in suggesting that early presentation, diagnosis and treatment
could mitigate its presumed severity [22].
In La Re ´union island, a French overseas department located in
Mascarene Archipelago (810,000 inhabitants, southwestern side of
the Indian Ocean), the first confirmed case of H1N1/09 influenza
was diagnosed on 5 July (week 27), in a traveler back from
Australia [23]. The human-to-human indigenous transmission was
declared by our regional surveillance system, the CIRE Reunion-
Mayotte (Cellule Inter-re ´gionale d’Epide ´miologie) of the French
Institute of Public Health and Surveillance (Institut national de
Veille Sanitaire, InVS), on week 30 (20 to 26 July) [23]. This alert
was made as part of enhanced influenza surveillance, implemented
soon after the first reported cases in the USA and anticipating the
flu season which started with the beginning of the austral winter in
July [24].
In order to characterize the spectrum of pdm (H1N1/09)v
throughout pregnancy and get a clear picture of its clinical burden
in pregnant women to provide unbiased information for risk
management, we designed an inception hospitalized-based cohort
study from a regional birth register, representative of the
reproductive population [25]. The main objective of our cohort
was to compare the clinical virulence of pdm flu during pregnancy
with that of influenza-like illnesses (ILIs) of non pdm origin (pdm
ILIs), using the most complete set of indicators of clinical
virulence. Additional aims included benchmarking the attack rate
in pregnant women to that of the non pregnant population, the
proportion of severe respiratory complications in pregnant women
and non pregnant women of childbearing age.
Methods
Study location and participants
Our prospective study took place in the three south Reunion
maternity departments (5,300 deliveries per year for a population
of 300,000 inhabitants): the two public level-3 and level-1
maternity wards of the Groupe Hospitalier Sud-Re ´union (GHSR),
the largest hospital on the island (standard care comparable to that
available in Europe, 4,100 deliveries per year), plus those of a
collaborative private level-1 maternity (1,200 deliveries per year)
[25].
We enrolled all pregnant women, parturient women and their
offspring referred for consultation or admitted at the maternity
departments between 5 July 2009 (date of the first pdm influenza
infection confirmed on the island) and 3 October 2009 (fall of the
outbreak). To minimize the rate of paucisymptomatic cases and
the possibility of underascertainment, general practitioners (GPs)
and ambulatory midwives were also invited to check flu symptoms,
using the REPERE (Re ´seau Pe ´rinatal Re ´union) network mailing
list, as well as to refer their patients to the hospital for virological
testing.
Ethical considerations
For the use of the data, oral consent was obtained from each
patient or a first-degree relative, as the investigations were carried
out under the standard care procedure for this infection, in
accordance with the dedicated amendment recommendations of
the Committee for Clinical Research of the GHSR which
approved specifically this observational study. In France, a written
consent is mandatory only if the medical acts or the products used
are not standard for the diagnosis, the treatment or the monitoring
(art. 88-II, law 2004-806, JO, 08/11/2004; art. 31-I, law 2006-
450, JO, 04/19/2006) [25]. The information was given by a senior
physician in face to face, in French or in Creole with the help of a
translator when necessary. This included a brief presentation of
the study, the terms of virological testing and antiviral treatment,
as indicated by the French College of Gynecologists and
Obstetricians (CNGOF) [26], as well as the return of RT-PCR
result in a sealed envelope.
Data Collection and Screening
Midwives and nurses collected full obstetric history from
maternity booklets and additional questioning in the framework
of our daily epidemiologic perinatal survey [25]. These includes
comorbidities, the commonest flu symptoms: rhinorrhea, conjunc-
tivitis, sore throat, cough, shortness of breath, headache, backache,
muscle ache, joint pain, fever, nausea, vomiting, diarrhea and
asthenia, enabling to redefine ILI in accordance with its widely
used definition [17].
For symptomatic women, whether presenting for examination
at the outpatient clinic or for hospitalization in the obstetrical unit,
one-step TaqMan RT-PCR assays were performed from naso-
pharyngeal swabs, serum, placenta, or amniotic fluid samples
using the Light Cycler 2.0 system or Light Cycler 480 (Roche
Diagnostics). For the women referred late in the course of their flu,
diagnosis of influenza was conducted retrospectively using serum
complement fixation testing. This technique enables the detection
of antibodies specific to influenza A or B antigens. A four-fold rise
of antibodies titers against A or B antigens in paired sera or a titer
at least of 1:80 (five dilutions) were considered to define recent
influenza with accuracy [27].
Case ascertainment
An ILI was defined in presence of at least one of the common flu
symptoms listed above. A confirmed case of pdm influenza was
defined as an ILI with positive A(H1N1/09)v RT-PCR. A
probable case of pdm flu was defined as an ILI with positive
influenza A, but negative H1 and H3 for seasonal variants test, or
with a positive A serology. A confirmed or probable case of pdm
influenza was referred as pdm flu. A case of ILI without criteria of
pdm flu, or diagnosed as seasonal flu, was referred as non pdm ILI.
An additional group referred as controls accounted for non ILI
pregnant women who gave birth in June 2009, the preceding
month the influenza occurrence. Finally, a subsidiary group was
extracted from hospital statistics and constituted by ILIs in non
pregnant women of reproductive age (15–44 yrs) assessed in the
Emergency Department (ED) during the influenza season without
formal evaluation of (H1N1/09)v status.
Pneumonia was defined for an acute respiratory illness with
audible crackles and chest infiltrates on X-ray films. Acute Lung
Injury (ALI)/ARDS were defined in presence of bilateral
H1N1 Influenza in Pregnancy
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and 300 or less than 200 Torr, respectively.
In the absence of earlier infection, maternal ILI was classified as
ante partum in women whose clinical signs had occurred between
the conception and the seventh day preceding labor (d-7) to
account for a seven-day maximal length of influenza viral shedding
under oseltamivir [28]. Maternal ILI was classified as per partum
when symptoms occurred between d-7 and d+7 around delivery
with a concomitant positive RT-PCR, and post partum for any
women presenting symptoms beyond d+7.
Exposed neonates were checked twelve hours after birth by RT-
PCR assay using nasopharyngeal and/or oral swabs. For the
neonates born from a symptomatic mother in per partum or in
early post partum, additional RT-PCR tests were performed on
serum at day 0 and/or during the first week of life.
Management of pregnant women
None of the non pharmaceutical measures addressed to mitigate
the incidence and severity rates of pdm influenza in the
community was fully applied in La Re ´union, as part of a public
health priority to protect the pregnant woman, beyond the fact
that healthcare providers (HCPs) were invited to treat pregnant
women separately, preferentially as outpatients, using surgical
masks and alcoholic solutions, as advocated by the CNGOF [26].
At household level, oseltamivir (75 mg once a day for 10 d) was
given to the relatives to avoid household transmission, as the
epidemic occurred before the availability of vaccines in France.
At hospital level, high and low viral density areas were drawn,
and HCPs wore FFP2 or surgical masks and used alcoholic
solutions to avoid transmission to the pregnant women in
maternity setting. In case of fever, women were checked to rule
out alternative diagnoses such as pyelonephritis, chorioamniotitis,
listeriosis, dengue and chikungunya. After RT-PCR testing,
women were treated using oseltamivir (75 mg two times per d for
five d) and quarantined until negativation of nasal swab, in
accordance to CNGOF recommendations [26].
Statistical Methods
To estimate the regional attack rate in pregnant women, we
derived the cumulative incidence rate (CIR) observed in the
framework of the South Reunion perinatal survey to the whole
island territory, assuming Tb, the overall regional births as a
constant (Tb<11,000), the number of births in the south per nine
month as a constant (Sb<4,100) and a proportional factor, the k
factor (k=Tb:Sb=2,68). We then compared the CIR in pregnant
women to the figure provided by the surveillance system for the
community [29], after removing the pregnancies-specific burden.
Clinical cases were classified as mild or severe influenza
(pneumonia, ALI/ARDS, ICU admission). Preterm labor (PTL)
was defined in presence of painful regular uterine contractions and
cervical changes occurred between 22 and 37 wks of amenorrhea.
Adverse pregnancy outcomes included preterm premature
rupture of membranes (PPROM), gestational diabetes mellitus
(GDM) and pregnancy-induced hypertension (PIH), most gesta-
tion issues (miscarriage, stillbirth, preterm live birth, PTLB) and
the mode of delivery. Neonatal outcomes gathered congenital
malformations (EUROCAT, European surveillance for Congen-
ital Abnormalities definition [30]), intra-uterine growth (Oken
charts [31]), fetal heart abnormalities during labor, amniotic fluid
quality, one-minute Apgar score, neonatal survival and early-onset
neonatal influenza infections.
Pandemic flu cases were compared with non pdm ILIs in terms
of circulating viremia, clinical presentation, severe influenza
respiratory complications, adverse pregnancy and neonatal
outcomes, as indicators of clinical virulence.
Hospitalized pdm flu pregnant women were roughly compared
to the non pregnant women of reproductive age in terms of
pneumonia and in terms of admission to the ICU.
Pregnant women with pdm flu or with non pdm ILI were
subsequently compared with all the control pregnant peers,
assuming as neglected the possibility that asymptomatic forms
would change significantly the relationship with pregnancy issues
in flu cases.
Exposed neonates born from infected mothers were compared
with unexposed controls on congenital malformations, growth,
amniotic fluid, fetal heart rate, one-minute Apgar score and
survival.
Proportions were compared using Chi square or Fisher exact
tests as appropriate. Continuous variables were compared using
Student or Mann-Whitney tests as appropriate. Risk ratios (RRs)
were calculated with standard methods and 95% confidence
intervals (95% CI) using Taylor series. All analyses were computed
in Stata (release 9; StataCorp. 2005, Texas, USA). Statistical
significance was set at P=0.05 for all analyses, except for those of
adverse pregnancy and neonatal outcomes for which a Bonferroni
correction was applied at P=0.01 to account for multiple
comparisons.
Results
During the twelve-wk of the pdm wave in La Re ´union, which
lasted for pregnant women from July 13 (wk 29) to October 3 (wk
40), out of 4,100 estimated ongoing pregnancies, 294 (7%)
pregnant women were referred to a flu-dedicated consultation in
one of the three South Reunion maternity departments,
representing nearly half of the obstetrical visits during that period
(45%, 294/653 passages). Out of these, 278 (95%) were checked
for influenza viruses using a Pasteur specific RT-PCR assay (Table
S1). The distribution of the pregnant women ascertained for flu
symptoms in South Reunion maternities throughout the
2009 pdm wave is presented in Fig. 1.
Weekly case numbers of maternal ILIs and pdm H1N1/09
influenza are displayed on separate epidemic curves in Fig. 2 and
Fig. 3. The CIR of probable or confirmed cases of pdm H1N1/09
flu derived from south Reunion birth register was estimated at
3.6% (95%CI: 3.3%–3.9%), leading to a regional cumulative case
estimate during pregnancy of 392 cases, or 3,568 cases per
100,000 pregnant women (95%CI: 3,267–3,868). In comparison,
the attack rate for the non pregnant community, once entrenched
the pregnancies-specific burden (392 cases/11,000 estimated
ongoing pregnancies), was 12.8% (relative risk reduction for
pregnant women: 0.75, 95%CI: 0.72–0.77).
The timing of ILI onset through pregnancy is presented in
Table S1. Out of the 251 women of ante partum onset (126 with
pdm flu and 125 with non pdm ILI), none of the six confirmed
pdm flu assessed by serum RT-PCR had detectable viremia,
irrespective of the time of ILI from mid- to late pregnancy,
precluding the possibility that severe third-trimester flu could be
attributable to viremia. In the same manner, out of the 27 ILIs of
per partum onset (13 with pdm flu, 14 with non pdm ILI), none of
the fifteen parturients for whom such specimen was collected (10
with pdm flu, 5 with non pdm ILI), exhibited the molecular
signature of influenza genome in serum, excluding vertical
mother-to-child transmission at birth via a placental breakdown
or a microtransfusion from a highly viremic maternal blood.
Importantly, placenta (n=22) or amniotic fluid (n=7) specimens
H1N1 Influenza in Pregnancy
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through placental or ‘‘all mucosal’’ routes.
None of the pregnant women declared a previous immuniza-
tion, since H1N1/09 vaccines were not yet available in the
southern hemisphere and seasonal flu and pneumococcal vaccines
not recommended for pregnant women at the time of our study.
Baseline characteristics and previously recognized risk factors for
severe pdm flu (origin, obesity, smoking, asthma) did not differ
according to the origin of flu in pregnant women (Table 1).
The median duration of symptoms from onset to flu-dedicated
consultation was two days, irrespective of diagnosis. The clinical
features of pdm flu and non pdm ILIs are depicted in Table 2.
The body temperature peak was higher in pdm flu than in non
pdm ILIs (38.9uC vs 38.3uC, P,0.0001), but the length of fever
(48 hrs) was indistinct between the two groups. Pdm flu cases were
more likely febrile than non pdm ILIs. Accordingly, they fulfilled
better the definition of ILI used in the USA (fever plus either
cough or sore throat [17]) than non pdm ILIs (Table 2).
The leukocyte count was lower in pdm flu than in non pdm ILI.
The biologic parameters characterizing pdm flu and non pdm ILI
are displayed in Table 3.
Oseltamivir was given in 218 (80%) out of the 271 women
compared for flu symptoms (86% for pdm vs 75% for non pdm
ILl, P=0.02), which was indicative of inappropriate use in a third.
The median delay to start oseltamivir from the onset of symptoms
was less than two days in both groups. The median time for
apyrexia was two days in both groups and was not shortened by
oseltamivir.
The overall ratio of hospitalized to ambulatory cases was 1.1
(52% to 47%). The admission rate to the obstetrical unit was
higher in pdm flu than in non pdm ILIs (60% vs 48%, crude RR
1.3, 95%CI: 1.0–1.6, P=0.04) and tended to correlate with the
stage of gestation (65% in third, 62% in second, 43% in first
trimester, P=0.09). Extrapolating this admission rate on a
regional basis led to estimate the hospitalization rate for pdm flu
at 2% of the pregnant women (95%CI: 1.8%–2.3%). The
principal motives for admission to the obstetrical unit with pdm
flu were protracted fever requiring monitoring and ruling out
other diagnoses (69%), PTL (14%), decreased fetal movements or
fetal heart abnormalities (10%). Taken together, in pdm flu,
underlying conditions and comorbidities (obesity, smoking,
asthma, GDM, PIH), were not more frequent in inpatients than
in outpatients (53% vs 44%, P=0.25). The median length of stay
(LOS) for pdm flu was three days (range 6 hrs–12 d).
Importantly, severe respiratory complications were observed
exclusively with H1N1/09 influenza. Six cases of pneumonia were
diagnosed with pdm flu (crude RR: 2.0, 95%CI: 1.7–2.3,
P=0.03), which represented barely 7% of hospitalized women
(median LOS: five d, range 2–7 d). No ARDS case was noted,
however seven cases of pdm flu required oxygen therapy (Six of
whom treated in obstetrical unit with high-concentration bags, one
ALI case admitted to the ICU for a 4-d mechanical ventilation).
Fourteen patients used b2 mimetics for asthma symptoms (Table
S2). The risk factors for severe pdm influenza (defined as
pneumonia or severe asthma) are presented in Table 4.
Compared to non pregnant women of reproductive age (15–
44 yrs) seen in the ED, hospitalized pdm flu pregnant women
carried not an excess risk of pneumonia (6/84 vs 7/109, crude RR:
Figure 1. Flow chart of pregnant women with flu symptoms,
maternity department, Saint-Pierre, Reunion Island, 2009.
doi:10.1371/journal.pone.0010896.g001
Figure 2. Pregnant women with flu symptoms, maternity
department, Saint-Pierre, Reunion Island, 2009. Weeks, from 5
July (w28) to 3 October (w40).
doi:10.1371/journal.pone.0010896.g002
Figure 3. Pregnant women with confirmed influenza virus,
maternity department, Saint-Pierre, Reunion Island, 2009.
Weeks, from 5 July (w28) to 3 October (w40).
doi:10.1371/journal.pone.0010896.g003
H1N1 Influenza in Pregnancy
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109, crude RR: 0.4, 95%CI: 0.0–2.6).
Overall, pregnancies with flu were twofold more likely to
experience PTL than uninfected pregnant controls (crude RR 2.2,
95%CI: 1.4–3.2, P=0.0001). Importantly, uterine contractility
associated with flu was mild and controlled by usual means for
tocolysis (bed rest, calcium channels blockers, salbutamol). Hence,
only one seasonal flu case led to impending PTLB. Gestational
diabetes mellitus tended to occur more frequently within pdm flu
than in uninfected pregnancies (13% vs 7%, crude RR 1.7,
95%CI: 1.0–2.6, P=0.03). However, half of the GDM cases were
diagnosed after the onset of pdm flu. After careful exclusion of
alternative causes, none miscarriage or stillbirth was attributable to
pdm flu. None other adverse pregnancy outcome was significantly
associated with influenza (Table 5).
Four congenital birth defects were diagnosed in neonates
born from mother reporting ILI during pregnancy, one in the
pdm flu group (ventricular septal defect, n=1), three in the non
pdm ILI group (cleft lip without cleft palate, n=1, cleft lip with
cleft palate, n=1, hypospadias, n=1). After careful examination
of the chronology of ILI onset with respect to embryogenesis,
none malformation was attributable to fever or influenza. At
time of labor, parturient women experiencing concomitant flu
did not exhibit more fetal heart abnormalities, meconium-
stained fluid, low one-minute Apgar score than uninfected
peers. None adverse neonatal outcome was associated with
influenza (Table 6).
The event of a mother-to-child vertical transmission of pdm
influenza virus was sought for eleven neonates exposed long before
birth, and for eleven neonates from mothers newly infected around
Table 1. Characteristics of pregnant women (PW) with 2009 pdm H1N1-v infection or with influenza-like illness (ILI) unrelated to
2009 pdm H1N1-v, uninfected pregnant women and non pregnant women of childbearing age (15–44 years) with ILI of indistinct




pdm ILI P value* Uninfected PW P value**
Non PW with
indistinct ILI P value***
(n=139)
1 (n=131) (n=440) (n=108)
11
Maternal age (years) 0.1368 0.0023 0.0005
,18 12 (8.6) 6 (4.6) 26 (5.9) 17 (15.7)
18 – 29 96 (69.1) 89 (67.9) 241 (54.7) 58 (53.7)
30 – 39 30 (21.6) 30 (22.9) 149 (33.9) 21 (19.4)
$40 1 (0.7) 6 (4.6) 24 (5.5) 12 (11.1)
Place of Birth 0.5316 0.0189 0.1842
La Re ´union 113 (81.3) 107 (81.7) 363 (82.5) 62 (81.6)
Mainland France 22 (15.8) 18 (13.7) 37 (8.4) 7 (9.2)
Other neighboring islands 3 (2.2) 6 (4.6) 38 (8.6) 7 (9.2)
Others 1 (0.7) 0 2 (0.5) 0
Parity 0.8844 0.5186 0.0806
Nullipara 48 (34.5) 48 (36.7) 168 (38.2) (49.4)
Primipara 47 (33.8) 45 (34.3) 123 (27.9) (18.5)
Multipara 44 (31.7) 38 (29.0) 149 (33.9) (32.1)
Weeks pregnant at infection 0.7658 NA NA
0 – 13 28 (20.1) 31 (23.7) –
14 – 28 56 (40.3) 49 (37.4) – –
.29 55 (39.6) 51 (38.9) – –
Overweight/obesity
{ 0.2491 0.51 0.0004
Yes 67 (48.2) 54 (41.2) 186 (45.4) 15 (25.3)
No 72 (51.8) 77 (58.8) 224 (54.6) 26 (74.7)
Smoking 0.4660 0.1329 0.6433
Yes 27 (19.4) 21 (16.0) 56 (12.7) (15.0)
No 112 (80.6) 110 (84.0) 384 (87.3) - 87.0)
History of current asthma 0.1402 NA 0.0067
Yes, currently receiving drugs 8 (5.8) 2 (1.5) – 14 (13.1)
Yes, not currently receiving drugs 8 (5.8) 5 (3.8) – 5 (4.7)
No 123 (89.4) 124 (94.7) – 88 (82.2)
Data are numbers (and percentages in parentheses); pdm flu vs non pdm ILI (line 1* line 2* column 1* column 2);
**pdm flu vs non pdm ILI vs uninfected peers ([L1+L2]*L3*C1*C2*C3); **pdm flu vs non pdm ILI vs uninfected peers ([L1+L2]*L3*C1*C2*C3);
{body mass index $25 kg/m2;
1 127 PCR+ confirmed H1N1/09 infections, 12 probable H1N1/09 infections (11 PCR+, 1 CF serology+), two H1N1/09 with influenza B virus coinfections excluded;
11 Data retrieved from medical informatic charts, completed by a telephonic survey, missing data excluded from calculation.
doi:10.1371/journal.pone.0010896.t001
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was found in the first week of life. One neonate was found a
healthy carrier of H1N1/09v soon after birth, presumably owing
to maternal post partum contamination. He was a small-for
gestational age neonate delivered from a previously healthy
woman by cesarean section for fetal heart decelerations after
24 hours of maternal fever due to pdm influenza. Maternal and
infant nasal swabs returned positive at d0. Maternal viremia and
placental specimen were negative. The infant remained asymp-
tomatic apart from hypoglycemia placed on the account of growth
restriction. He was treated with oseltamivir for five days without
side-effects. His RT-PCR control at d7 was negative.
During the twelve-wk pdm wave, only two neonates were
referred late in neonatal care unit for mild symptoms (at d17 and
d21 respectively), due to household transmission.
Discussion
This hospitalized-based cohort, designed from a well-tested
regional representative birth register [25], identified all pregnant
women referred to the South Reunion Island maternities for ILI or
any complaint compatible with flu throughout the 2009 pdm
influenza wave, which occurred in La Re ´union, between July 13
(wk 29) and October 3 (wk 40), during the austral winter season.
Therefore, we were able to accurately determine the clinical
burden of non pdm ILI and pdm influenza during pregnancy on a
regional basis. Our findings, acquired without major selection bias
nor critical strain on the healthcare supply, mitigate historical and
recent disturbing data on severe pdm influenza in pregnant
women highlighting increased risks for hospitalization or admis-
sion to the ICU [4,6,13–21]. Interestingly, this current overview
provides some arguments to demonstrate the low clinical virulence
of pdm influenza (H1N1/09)v, in a context of a public health
response focused on the prompt identification of clinical cases and
managing clusters of infections with widespread use of anti-
influenza drugs.
First, despite extensive research, we did not find any evidence
for a circulating viremia that could have explained the peculiar
severity of 2009 pdm influenza in pregnant women, gradually as
the gestation progresses. Hence, circulating viremia, which is
scarcely observed with seasonal flu [32], would have been a
hallmark of clinical virulence, reminiscent of highly pathogenic
H5N1 avian flu [33]. The absence of circulating viremia in such
susceptible human group is in agreement with small animal
models and a non-human primate model for which no evidence of
viremia have been reported [10–12].
Second, the clinical presentation of laboratory-confirmed
2009 pdm influenza was not substantially different from that of
non pdm ILIs, beyond the fact that it was more febrile and
symptomatic. The latter is congruent with the seminal description
of swine flu in humans [34], and consistent with the absence of
previous herd immunity against this triple-reassortant virus.
Noteworthy, vomiting and diarrhea, which were highlighted
indicators of severity, both in ferrets and in humans [10,11,34],
were very infrequent in our cohort. Similarly, shortness of breath,
previously described as harbinger of poor respiratory compliance
in US pregnant women with 2009 pdm influenza [17], was
indistinct of pdm flu or non pdm ILI. Furthermore, leukocyte
count was lower in women with pdm flu than in those with non
pdm ILI, and consisted almost invariably in lymphopenia.
However, marked lymphopenia (,750 per cubic millimeter) was
not associated with severe illness. Severe lymphopenia, which is
predictive of fatal ARDS in H5N1 avian flu [35], has also been
found indicative of severe 2009 pdm influenza [36]. Like in
seasonal influenza, its mechanism would involve apoptosis via the
fas-fasL pathway [37].
Table 2. Clinical features of 2009 pdm H1N1-v infection and of influenza-like illnesses (ILI) unrelated to 2009 pdm H1N1-v,
pregnant women, Saint – Pierre, Reunion Island, 5 July to 3 October 2009.
2009 pdm flu non pdm ILI P value
Clinical symptoms (n=139)
1 (n=132)
Fever above 37.8uC 127 (91.4) 93 (70.5) ,0.0001
Rhinorrhea 100 (71.9) 105 (79.5) 0.1449
Conjunctivitis 4 (2.9) 9 (6.8) 0.1292
Sore throat 83 (59.7) 87 (65.9) 0.2916
Cough 126 (90.6) 120 (90.9) 0.9407
Shortness of breath 19 (13.7) 20 (15.2) 0.9824
Backache 43 (30.9) 36 (27.3) 0.5072
Muscle ache 47 (33.8) 35 (26.5) 0.1911
Joint pain 41 (29.5) 25 (18.9) 0.0430
Nausea 19 (13.7) 13 (9.8) 0.3299
Vomiting 14 (10.1) 12 (9.1) 0.7840
Diarrhea 2 (1.4) 4 (3.0) 0.4372
Headache 15 (10.8) 12 (9.1) 0.6404
Asthenia 26 (18.7) 19 (14.4) 0.3405
Fever plus either cough or sore throat { 115 (83.3) 83 (62.3) 0.0002
Data are numbers (and percentages in parentheses) or medians (and Q1–Q3, the inter quartile range);
{defining influenza-like-illness for Jamieson et al. [17];
1127 PCR+ confirmed H1N1/09 infections, 12 probable H1N1/09 infections (11 PCR+, 1 CF serology+), two H1N1/09 with influenza B virus coinfections excluded; P value
set at 0.05 for statistical significance.
doi:10.1371/journal.pone.0010896.t002
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and contrasted sharply with the critical illness and the excess of
mortality due to ARDS encountered in pregnant women in the
rest of the world, evidenced by their overrepresentation in ICUs
and the deaths reported in the USA [5,18,19], Manitoba, Canada
[6,7], Australasia [4,9,21], or mainland France [38]. Nonetheless,
in our setting, pdm flu was associated with more frequent
pneumonia or severe asthma, as witnessed heightened needs for
oxygen rescue therapy. This finding should remind the primary
respiratory involvement of emerging influenza A viruses, otherwise
illustrated by alveolar damage in animal models [10–12],
ventilatory or ECMO supports in critically-ill young adults
[2–9], whose corollary, the access to ICU beds have represented
a major issue over the pandemic [4,39]. The basis of severe
respiratory involvement observed in pdm influenza during
pregnancy may be related to the conjunction of immunologic
and physiologic changes, including the switch from cell-mediated
to antibody-mediated immune responses, respiratory compromise
by mechanical effect, and heightened cardiopulmonary demand to
compensate the raised blood volume [17–21]. The paucity of
ALI/ARDS cases observed in La Re ´union may probably be
blamed to the awareness of local HCPs, as evidenced by the
prompt access to medical care. Indeed, early and easy access to
antiviral treatments may have reduced the progression towards
more severe disease and hereafter the admission rate to the ICU
and mortality [5–8]. The efficacy of oseltamivir in preventing
pneumonia and other influenza-related complications has long
been controversial in adults and poorly investigated in high-risk
groups [40,41]. The neuraminidase inhibitors action might be
larger than expected, both exhibiting antiviral and antipneumo-
coccal synergistic properties, limiting the sialidase activity of
Streptococcus pneumoniae [42], which may have contributed to contain
pneumococcal disease during the pandemic.
Fourth, the ability of pdm H1N1/09 influenza to disrupt the
natural course of gestation is not confirmed by our study.
Certainly, like other investigators [20], we observed more PTL
among pregnancies accompanied by pdm flu (14% vs 8% in
uninfected controls). However, uterine contractility was mild and
well-controlled by tocolytics. Subsequently, the annual incidence
of PTLB (10%) was unchanged in South Reunion. As PTB was
related to untractable pneumonia in previous influenza pandemics
[13,14,16], we may explain the absence of impact of pdm (H1N1/
09)v on PTLB by the low proportion (4.2%) and benignity of
Table 3. Biological features of 2009 pdm H1N1-v infection
and of influenza-like illnesses (ILI) unrelated to 2009 pdm
H1N1-v, pregnant women, Saint – Pierre, Reunion Island, 5
July to 3 October 2009.






7.5 (5.9 – 9.0) 8.8 (6.7–10.9) 0.0012
, 4,000 4 (3.6) 0 0.0021
4,000 – 10,000 90 (80.4) 56 (65.1)




5.7 (4.3–7.2) 6.2 (5.1–8.8) 0.1548
, 1,500 2 (1.8) 0 0.0359
1,500 – 8,500 95 (84.8) 60 (74.1)




0.9 (0.6–1.3) 1.0 (0.7–1.5) 0.3283
, 750 39 (34.8) 25 (30.9) 0.2535
750 – 1,500 56 (50.0) 36 (44.4)




209 (174–264) 221 (186–272) 0.9669
ASAT (U/L) 21 (16–30) 18 (15–23) 0.2598
ALAT (U/L) 14 (10–19) 12 (9–15) 0.1734
Creatinine (mmol/L) 48 (42–56) 47 (41–56) 0.5524
Potassium (mmol/L) 3.8 (3.6–4.0) 3.9 (3.7–4.1) 0.2654
C-Reactive Protein
level (mg/L)
26.0 (14.7–46.0) 22.4 (12.0–
36.6)
0.3861
, 25 54 (49.1) 50 (56.8) 0.2112
25–50 35 (31.8) 29 (33.0)
. 50 21 (19.1) 9 (33.0)
Data are numbers (and percentages in parentheses) or median (and Q1–Q3,t h e
inter quartile range);
1103 PCR+ confirmed H1N1/09 infections, 9 probable H1N1/09 infections
(8 PCR+, 1 CF serology+), two H1N1/09 with influenza B virus coinfections
excluded; P value set at 0.05 for statistical significance.
doi:10.1371/journal.pone.0010896.t003
Table 4. Risk factors for severe pandemic influenza, pregnant women, Saint – Pierre, Reunion Island, 5 July to 3 October 2009.
Severe 2009 pdm flu Mild 2009 pdm flu P value
(n=10)
1 (n=129)
Indigenous to Indian Ocean
a 9 (90.0) (82.9) 1
Overweight/Obesity
{b 5 (50.0) 62 (48.1) 1
Smoking
c 1 (10.0) 26 (20.2) 0.6867
Asthma
d 2 (20.0) 14 (10.9) 0.3231
Delay to start oseltamivir (hrs) 62.7 (61.7) 41.3 (27.2) 0.0524
At least one of these conditions
a+b+c+d 9 (90.0) 68 (52.7) 0.0425
Two conditions 0 14 (10.9) NA
Three conditions 0 2 (1.6) NA
Data are numbers (and percentages in parentheses) or means (and standard error);
{body mass index $25 kg/m
2;
1defined as pneumonia or severe asthma requiring oxygen; P value set at 0.05 for statistical significance.
doi:10.1371/journal.pone.0010896.t004
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in PTLB rates between pdm flu and uninfected controls (Table 5)
with a 3.4% pdm flu CIR (a=0.05, 1–b=0.8), it would have
required enrolling over 1,800 infected pregnant women in our
cohort. Similarly, at Re ´union island (where the baseline GDM rate
has reached 7% for a couple of years [43]), pdm influenza (H1N1/
09)v was linked to heightened GDM rate like recently observed in
Victoria, Australia [20]. However, while there, a cross-sectional
study design did not allow to conclude on the chronological
relationship between GDM and pdm flu (and vice versa), our
cohort reveals that in half the cases GDM occurred before pdm
flu, in half the cases pdm flu had preceded GDM, which argues
definitely against a causal relationship between the two conditions.
Nevertheless, the fact that year 2009 was associated with the
record of GDM registered in our database (7.5%) raises questions,
even if during the same time, overweight and obesity, its common
determinants, have grown steadily (+2%, from 34% to 36%, from
14% to 16%, respectively).
Five, pdm influenza (H1N1/09)v infection was neither associ-
ated with a significant rise of congenital malformations, nor with
early-onset neonatal influenza infections. The effects of maternal
influenza on the fetus, whether due to fever or to a transplacental
transmission of the virus are poorly understood [16]. The crossing
of the placental barrier by a microbial pathogen is an essential
indicator of virulence [44]. To date, except with highly pathogenic
H5N1 avian strains [45], the placental transmission of influenza
viruses lacks of evidence [16]. In this, our study adds molecular
proof to the large seroepidemiological study of Irving et al. who
did not find such aptitude with seasonal flu [46]. Importantly,
except one healthy carrier of probably post partum transmission of
maternal origin, we observed no early-onset neonatal influenza
infection. This suggests more the harmlessness of pdm influenza
Table 5. Obstetrical outcomes associated with 2009 pdm H1N1-v infection or with influenza-like illnesses (ILI) unrelated to
2009 pdm H1N1-v or with uninfected controls, pregnant women, Saint – Pierre, Reunion Island, 5 July to 3 October 2009.
2009 pdm flu non pdm ILI P value* Controls P value**
(n=139)
1 (n=132) (n=445)
Preterm labor 0.3202 0.0007
Yes, concomitant to flu 13 (11.3) 8 (80.9) -
Yes, unrelated to flu 9 (7.8) 14 (12.1) 38 (8.9)
No 93 (80.9) 93 (80.9) 392 (91.2)
Preterm premature rupture of membranes 1 0.1257
Yes, concomitant to flu 1 (0.9) 1 (0.9) -
Yes, unrelated to flu 1 (0.9) 2 (1.7) 3 (0.7)
No 113 (98.2) 112 (97.4) 427 (99.3)
Gestational diabetes mellitus 0.0647 0.0327
Yes, after onset of flu 8 (7.0) 4 (3.5) -
Yes, preexistent to flu 7 (6.1) 1 (8.7) 30 (7.0)
No 100 (86.9) 110 (87.8) 400 (93.0)
Pregnancy-induced hypertension 0.5387 0.7031
Yes, after onset of flu 7 (6.1) 4 (3.5) -
Yes, preexistent to flu 0 1 (8.8) 17 (4.0)




{ 0 2 (1.7) 10 (2.2)
Stillbirth
{ 0 4 (3.5) 5 (1.1)
Very preterm livebirth (,33 wks) 3 (2.6) 2 (1.7) 6 (1.4)
Late preterm livebirth (33 to 36 wks) 14 (12.2) 10 (8.7) 28 (6.3)
Term delivery precipitated by flu 5 (4.3) 9 (7.8) -
Term delivery unchanged by flu 93 (80.9) 88 (76.5) 396 (89.0)
Mode of delivery
" 0.5773 0.7485
Vaginal 93 (80.9) 97 (84.3) 362 (84.1)
Caesarian section 21 (19.1) 18 (15.7) 68 (15.9)
Delivery expected in the forthcoming weeks
",1 24 17 -
Data are numbers (and percentages in parentheses);
*pdm flu vs non pdm ILI (line 1* line 2* column 1* column 2);
**pdm flu vs non pdm ILI vs uninfected peers ([L1+L2]*L3*C1*C2*C3);
"miscarriages and ongoing pregnancies excluded (censoring at 12 April 2010);
1ongoing pregnancies excluded;
{fetal demise ,16 wks;
{early, late ante and intra partum fetal death $16 wks;
1127 PCR+ confirmed H1N1/09.
doi:10.1371/journal.pone.0010896.t005
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measures used against its horizontal transmission. This is
consistent with the paucity of neonatal infections during the
pandemic.
Our study has some strengths and limitations. On the one hand,
using a cohort-study design in the framework of a birth register
within a public health context of awareness allowing caregivers not
to be reluctant to entrust their patients to hospital, has certainly
made possible a nearly exhaustive review of ILIs during
pregnancy. This assertion is made plausible by the fact that the
systematic examination of parturient women in the maternity
department, sometimes combined with complement fixation
testing, have detected only two new clinical cases among over
2,800 women who delivered in the six months following the pdm
wave. We could thereby accurately determine the burden of
H1N1/09 influenza without significant underreporting bias, nor
concurrent overestimation of severe influenza respiratory compli-
cations. On the other hand, the low critical mass of ongoing
pregnancies on the island of La Re ´union may have failed to
properly investigate the ratio of severe to mild H1N1/09 influenza
disease.
Indeed, with only 11,000 ongoing pregnancies, a crude estimate
of influenza-related critical illness in Australasia about 1:4,300
gestations (66 ICU stays for 285,000 ongoing pregnancies), we
were unable to show the role of pregnancy as a risk factor for
influenza-related critical illness in La Re ´union [18,21]. Similarly,
an excess of other rare events, such as congenital malformations or
fetal infection, could not be detected to a large scale in our setting,
unless teratogenicity or vertical transplacental transmission with
pdm influenza or oseltamivir is very frequent, which has never
been evidenced so far [16,47]. Nonetheless, with only six cases of
pneumonia and no ARDS for 84 laboratory-confirmed pdm
H1N1/09 influenza infections admitted to the hospital (one
pneumonia per 14 hospitalized infections), we were below the
expected range for hospitalized pneumonia (1:4 to 1:2) and outside
those of ARDS/pneumonia admitted to the ICU previously found
in pdm flu (1:14 to 1:2) [17,19,20]. Therefore, we were unable to
calculate the ARDS/infections ratio, which has been proposed as
indicator of clinical virulence [39]. Nevertheless, it must be
stressed that we enrolled only clinical cases in our cohort. The
knowledge of the asymptomatic/symptomatic ratio in pregnant
women would have provided another clue upon the clinical
virulence in this population, that being attenuated in case of
predominant inapparent forms. A recent study in the French adult
population of reproductive age (20–39 yrs), confronting data from
serosurveys in pregnant women to those of the Sentinelles
Network, estimated at 4:1 this ratio [48].
In conclusion, this report from La Re ´union Island, which was
representative of the population of the pregnant women in the
area, mitigates substantially the severity of pdm H1N1/09
influenza infection during pregnancy. Whether its findings
proceed from local physician skill and good preparedness, or
Table 6. Neonatal outcomes associated with 2009 pdm H1N1-v or with influenza-like illnesses (ILI) unrelated to 2009 pdm H1N1-v
exposures or with unexposed controls, Saint – Pierre, Reunion Island, 5 July to 3 October 2009.




" 0.6125 - NA
Ante partum (, D-7) 129 (90.8) 115 (88.5) -
Per partum (from D-7 to D+7) 13 (8.2) 14 (10.7)
Post partum (. D+7) 0 0 (0.8)
Congenital malformations
{," 0.6125
Yes, subsequent to flu 0 0 -
Yes, preexisting to flu 1 (0.9) 3 (2.6) 5 (1.1)
No 116 (99.1) 112 (97.4) 435 (98.9)
Small for Gestational age
{," 0.8040 0.478
Yes 14 (12.0) 15 (13.0) 42 (9.5)
No 103 (88.0) 100 (87.0) 398 (90.5)
One-minute Apgar score
" 1 0.5694
,7 4 (3.4) 3 (2.6) 22 (5.0)
7 to 10 113 (96.6) 112 (97.4) 418 (95.0)
Neonatal issue
" 0.2155 0.5112
Death 0 1 (0.9) 5 (1.1)
Discharged from neonatal unit 8 (6.8) 3 (2.6) 21 (4.8)
Discharged from nursery 109 (93.2) 111 (96.5) 414 (94.1)
Expected (pregnancy on course)
",1 25 15 -
Data are numbers (and percentages in parentheses); pdm flu vs non pdm ILI (line 1* line 2* column 1* column 2);
**pdm flu vs non pdm ILI vs uninfected peers ([L1+L2]*L3*C1*C2*C3);
"expected births, miscarriage and stillbirths excluded (censoring at 12 April 2010);
1ongoing pregnancies excluded;
{ EUROCAT definition [30];
{small for gestational age neonates are defined under 10
th percentile using Oken growth charts [31];
1127 PCR+ confirmed H1N1/09 infections, 12 probable H1N1/09 infections (11 PCR+, 1 CF serology+), two H1N1/09 with influenza B virus coinfections excluded; P value
set at 0.01 for statistical significance (Bonferroni correction).
doi:10.1371/journal.pone.0010896.t006
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PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10896from a low clinical virulence of the virus in the region, raises
concerns at the time when public health agencies and policy-
makers draw up the balance of the pandemic. Finally, phyloge-
netic studies of triple-reassortant pdm influenza virus strains linked
to clinical descriptions are warranted to better understand the
reasons for which the clinical burden of H1N1/09 influenza virus
may differ worldwide.
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